跳至主要内容
临床试验/NCT03062072
NCT03062072Unknown不适用

Emergence of Chemotherapy Related Hyperglycemia in nOn-diabetic Patients (ECHO)

National Cancer Center, Korea2 个研究点 分布在 1 个国家目标入组 300 人开始时间: 2015年4月最近更新:
适应症
相关药物

试验速览

阶段
不适用
入组人数
300
试验地点
2
主要终点
Incidence of type 2 diabetes mellitus

研究概览

简要总结

To assess chemotherapy related hyperglycemia in non-diabetic patients, the investigators will assess the incidence of hyperglycemia and analyze co-medications and risk factors.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with cancers (colorectal, breast) who treated with curative intents and ones with malignant lymphoma who are expected to achieve complete remission with chemotherapy (mainly, CHOP regimen)
  • Patients without history of diabetes mellitus
  • Normal glucose tolerance, as defined in the protocol

排除标准

  • Patients with diabetes mellitus or hyperglycemia, as defined in the protocol

结局指标

主要结局

Incidence of type 2 diabetes mellitus

时间窗: during chemotherapy (about 1 year)

Percentage of patients who progressed to type 2 diabetes

次要结局

  • Change in glycated albumin(during chemotherapy (about 1 year))
  • Change in HbA1c(during chemotherapy (about 1 year))
  • Recurrence free survival (RFS)(from the Date of enrollment to the date of disease recurrence or date of any cause assessed upto 100 months)

研究者

申办方类型
Other Gov
责任方
Principal Investigator
主要研究者

Eun Kyung Lee

Principal Investigator

National Cancer Center, Korea

研究点 (2)

Loading locations...

相似试验